HLB INC. Logo

HLB INC.

A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.

028300 | KO

Overview

Corporate Details

ISIN(s):
KR7028300002
LEI:
Country:
South Korea
Address:
세종특별자치시 연동면 명학산단서로 10-5, 세종특별자치시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Based on available information, HLB INC. appears to be a diversified global entity with activities spanning multiple sectors. Public sources indicate a primary focus on the pharmaceutical and biotechnology industries, with an emphasis on developing anti-cancer drugs through an open innovation system. The group also includes divisions engaged in shipbuilding and advanced composite materials, life sciences focusing on diagnostics and medical devices, and electrical engineering solutions. Additionally, the name HLB is associated with a global network of independent advisory and accounting firms offering audit, tax, and consulting services. The company's content suggests a focus on emerging business reporting standards, such as ESG and EU regulations, across various industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 5.0 KB
2025-09-18 00:00
Registration Form
증권신고서(합병)
Korean 5.0 MB
2025-09-17 00:00
M&A Activity
[첨부추가]주요사항보고서(회사합병결정)
Korean 42.9 KB
2025-09-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 129.4 KB
2025-09-08 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.2 KB
2025-09-03 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 41.0 KB
2025-09-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 138.5 KB
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-28 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-08-28 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 11.1 KB
2025-08-20 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 43.1 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.8 MB
2025-08-01 00:00
M&A Activity
[기재정정]주요사항보고서(회사합병결정)
Korean 47.6 KB
2025-08-01 00:00
M&A Activity
기타경영사항(자율공시) (회사합병결정 철회에 관한 사항)
Korean 7.9 KB
2025-08-01 00:00
Registration Form
철회신고서
Korean 4.6 KB

Automate Your Workflow. Get a real-time feed of all HLB INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.